Laura Dillon, PhD, FACMG
@LauraWDillon
Followers
128
Following
349
Statuses
101
Research Associate Professor and Medical Geneticist at Virginia Tech FBRI Cancer Research Center in DC @FralinBiomed @virginia_tech | ❤️🧬 | comments my own
Joined December 2019
RT @DrChrisHourigan: #Tandem25 I'll be talking today (10.30am Ballroom B, 4th flr) about the Pre-MEASURE AML MRD project which used CIBMTR…
0
2
0
RT @DrChrisHourigan: Delighted to have Dr. Dillon join us at the Virginia Tech @FralinBiomed Cancer Research Center in DC as Research Assoc…
0
3
0
New Year, new job, a fresh start. After almost 8 years of service at the NIH I am excited to be starting this year off joining @DrChrisHourigan at the @virginia_tech @FralinBiomed Cancer Research Center in Washington, DC. Exciting things to come.
3
1
29
RT @DrChrisHourigan: TP53 mutation screening for patients at risk of myeloid malignancy | Leukemia @Devdeep07 @LauraWDillon https://…
0
13
0
RT @Anand_88_Patel: Excellent new paper in @JAMAOnc by @LauraWDillon @DrChrisHourigan et al on FLT3-ITD MRD prior to allo-HCT in AML! The…
0
19
0
RT @ESHaematology: #ESHAL2024 @JordiEsteve17 chairs a very entertaining - and not entirely serious - debate discussing whether AML MRD conv…
0
5
0
RT @DrChrisHourigan: Secondary primary malignancies are increasingly recognized as a risk of cellular therapies (esp. MDS/AML, also after c…
0
25
0
@KatieLaiMD_MPH @dralainmina @theNCI @DrChrisHourigan Was great catching up and hearing about all your exciting work!
0
0
0
@DrChrisHourigan @KatieLindblad1 @IcahnMountSinai @HongYuenWong @VUMCDiscoveries Congrats Katie!!! So proud of you!
2
0
2
@DrChrisHourigan Sorry I couldn’t be there in person at #ASH23 but happy to answer any questions! Happy to share this important data which provides insight for interpreting FLT3-ITD MRD information with important implications for clinical practice.
0
0
2
RT @DrChrisHourigan: Bottom lines: There does appear to be an association between level of FLT3-ITD persistence and clinical outcome (first…
0
1
0
RT @DrChrisHourigan: I encourage you to listen to the recorded poster presentation by @LauraWDillon (who is unable to attend ASH in person…
0
1
0
RT @DrChrisHourigan: Cleveland clinic medical student @ClevelandClinic @hegdepranay1 presenting work he did on FLT3-TKD MRD during a MR…
0
9
0
RT @DrChrisHourigan: She crushed it! First major international talk for @GegeGui0 - biostatistics PhD student and key member of staff in…
0
8
0
RT @DrChrisHourigan: Come listen (and support) Gege as she gives her first talk at an international hematology meeting! If we are serious…
0
1
0
RT @DrChrisHourigan: So proud of our HouriganLab #ASH23 superstar abstract award winners - biostats PhD student @GegeGui0 (oral on IDH2 M…
0
3
0
RT @DrChrisHourigan: Proud of @GegeGui0 & @hegdepranay1 for their @ASH_hematology abstract awards for work on the next stages of #PreMEASUR…
0
13
0
RT @DrChrisHourigan: The best and the brightest from medical, dental, and vet schools around the US come to @NIH for a year during training…
0
4
0
RT @Blood_Cancers: Persistent FLT3-ITD or NPM1 variants in pretransplant blood samples from patients with AML in their first remission were…
0
3
0